Skip to main content
Top
Published in: Cancer Cell International 1/2014

Open Access 01-12-2014 | Primary research

K-D:rib dampens Hs 578T cancer cell chemoinvasion and proliferation

Authors: Luca Bruni, Adesola A Babarinde, Ida Ortalli, Simonetta Croci

Published in: Cancer Cell International | Issue 1/2014

Login to get access

Abstract

Background

Cancer cells, even in the presence of available oxygen, have a glycolysis enhancement. The “aerobic glycolysis” is known as the Warburg effect and it is considered one of the fundamental hallmarks of metabolic alteration during malignant transformation. A feature of many tumors is also a change into ions equilibrium, with particular reference to K+ intracellular concentration. Another hallmark in cancer is the reprogrammed chemotaxis pathways in favour of tumor cell dissemination.

Results

The doubling population time of 5 mM K:D-rib treated Hs 578T (HTB-126 ® ATCC) cell line is reduce by 30% respect to the control. During the chemotactic invasion assay, the relative number of motile and invasive cells, counted inside the FBS-AGAR spot, shows a decrease with the maintenance of the treatment reaching the 25% after nine days. Hs 578Bst (HTB-125 ® ATCC) non-tumor cell line treated for nineteen days with 5 mM K:D-rib was split twice as well as the control. No morphological change was visible in the treated respect to untreated cells.

Conclusions

We demonstrate that the synergic action of potassium bicarbonate and D-ribose has effect on Hs 578T cancer cell line proliferation reducing the cell cycle time. At 5 mM concentration, K:D-rib is able to modify the tumorigenic potential of human breast cancer cell line Hs 578T, interfering in vitro with the capability of Hs 578 T cell line to migrate under chemotactic stimuli. Despite this, K:D-rib solution, does not exhibit any appreciable toxicity as confirmed by the proliferation assay accomplished on Hs 578Bst cell line.
Appendix
Available only for authorised users
Literature
1.
go back to reference Croci S, Pedrazzi G, Paoli G, Monetti D, Ortalli I: Potassium ascorbate as protective agent in the oxidation of the red blood cells. Hyperfine Interactions (C), in proceedings of the International Conference on the application of Mössbauer Effect (ICAME 2001) 2–7 Semptember 2001 Oxford UK, Volume 5. Edited by: Thomas MF, Williams JM, Gibb TC. 2001, 241-244. Croci S, Pedrazzi G, Paoli G, Monetti D, Ortalli I: Potassium ascorbate as protective agent in the oxidation of the red blood cells. Hyperfine Interactions (C), in proceedings of the International Conference on the application of Mössbauer Effect (ICAME 2001) 2–7 Semptember 2001 Oxford UK, Volume 5. Edited by: Thomas MF, Williams JM, Gibb TC. 2001, 241-244.
2.
go back to reference Croci S, Pedrazzi G, Passeri G, Delsignore R, Ortalli I: Red cell Hb oxidation of healthy subjects compared to breast cancer patients. Anticancer Res. 2002, 22 (5): 2903-2906.PubMed Croci S, Pedrazzi G, Passeri G, Delsignore R, Ortalli I: Red cell Hb oxidation of healthy subjects compared to breast cancer patients. Anticancer Res. 2002, 22 (5): 2903-2906.PubMed
3.
go back to reference Croci S, Pedrazzi G, Passeri G, Piccolo P, Ortalli I: Acetylphenylhydrazine induced haemoglobin oxidation in erythrocytes studied by Mossbauer spectroscopy. Biochim Biophys Acta. 2001, 1568 (1): 99-104. 10.1016/S0304-4165(01)00205-7.CrossRefPubMed Croci S, Pedrazzi G, Passeri G, Piccolo P, Ortalli I: Acetylphenylhydrazine induced haemoglobin oxidation in erythrocytes studied by Mossbauer spectroscopy. Biochim Biophys Acta. 2001, 1568 (1): 99-104. 10.1016/S0304-4165(01)00205-7.CrossRefPubMed
4.
go back to reference Boros LG, Lee PWN, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS, Ellison EC: Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?. Med Hypotheses. 1998, 50 (1): 55-59. 10.1016/S0306-9877(98)90178-5.CrossRefPubMed Boros LG, Lee PWN, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS, Ellison EC: Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?. Med Hypotheses. 1998, 50 (1): 55-59. 10.1016/S0306-9877(98)90178-5.CrossRefPubMed
5.
go back to reference Freeman ML, Mertens-Talcott SU, St Cry J, Percival S: Ribose enhances retinoic acid-induced differentiation of HL-60 cells. Nutr Res. 2008, 28 (11): 775-782. 10.1016/j.nutres.2008.09.007.CrossRefPubMed Freeman ML, Mertens-Talcott SU, St Cry J, Percival S: Ribose enhances retinoic acid-induced differentiation of HL-60 cells. Nutr Res. 2008, 28 (11): 775-782. 10.1016/j.nutres.2008.09.007.CrossRefPubMed
6.
7.
go back to reference Zhou XF, Su FY, Tian YQ, Youngbull C, Johnson RH, Meldrum DR: A new highly selective fluorescent K+ sensor. J Am Chem Soc. 2011, 133 (46): 18530-18533. 10.1021/ja207345s.CrossRefPubMedCentralPubMed Zhou XF, Su FY, Tian YQ, Youngbull C, Johnson RH, Meldrum DR: A new highly selective fluorescent K+ sensor. J Am Chem Soc. 2011, 133 (46): 18530-18533. 10.1021/ja207345s.CrossRefPubMedCentralPubMed
8.
go back to reference Parkinson GN, Lee MPH, Neidle S: Crystal structure of parallel quadruplexes from human telomeric DNA. Nature. 2002, 417 (6891): 876-880. 10.1038/nature755.CrossRefPubMed Parkinson GN, Lee MPH, Neidle S: Crystal structure of parallel quadruplexes from human telomeric DNA. Nature. 2002, 417 (6891): 876-880. 10.1038/nature755.CrossRefPubMed
9.
go back to reference Lipps HJ, Rhodes D: G-quadruplex structures: in vivo evidence and function. Trends Cell Biol. 2009, 19 (8): 414-422. 10.1016/j.tcb.2009.05.002.CrossRefPubMed Lipps HJ, Rhodes D: G-quadruplex structures: in vivo evidence and function. Trends Cell Biol. 2009, 19 (8): 414-422. 10.1016/j.tcb.2009.05.002.CrossRefPubMed
10.
go back to reference Kelland LR: Overcoming the immortality of tumor cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer. 2005, 41 (7): 971-979. 10.1016/j.ejca.2004.11.024.CrossRefPubMed Kelland LR: Overcoming the immortality of tumor cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer. 2005, 41 (7): 971-979. 10.1016/j.ejca.2004.11.024.CrossRefPubMed
11.
go back to reference Croci S, Bruni L, Bussolati S, Castaldo M, Dondi M: Potassium bicarbonate and D-ribose effects on A72 canine and HTB-126 human cancer cell line proliferation in vitro. Cancer Cell Int. 2011, 11: 30-10.1186/1475-2867-11-30.CrossRefPubMedCentralPubMed Croci S, Bruni L, Bussolati S, Castaldo M, Dondi M: Potassium bicarbonate and D-ribose effects on A72 canine and HTB-126 human cancer cell line proliferation in vitro. Cancer Cell Int. 2011, 11: 30-10.1186/1475-2867-11-30.CrossRefPubMedCentralPubMed
12.
go back to reference Anichini C, Lo Rizzo C, Longini M, Paoli G, Di Bartolo RM, Proietti F, Buonocore G: Beckwith-Wiedemann syndrome: potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk. Anticancer Res. 2011, 31 (11): 3973-3976.PubMed Anichini C, Lo Rizzo C, Longini M, Paoli G, Di Bartolo RM, Proietti F, Buonocore G: Beckwith-Wiedemann syndrome: potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk. Anticancer Res. 2011, 31 (11): 3973-3976.PubMed
13.
go back to reference Anichini C, Lotti F, Pietrini A, Lo Rizzo C, Longini M, Proietti F, Felici C, Buonocore G: Antioxidant effects of potassium ascorbate with ribose in costello syndrome. Anticancer Res. 2013, 33 (2): 691-696.PubMed Anichini C, Lotti F, Pietrini A, Lo Rizzo C, Longini M, Proietti F, Felici C, Buonocore G: Antioxidant effects of potassium ascorbate with ribose in costello syndrome. Anticancer Res. 2013, 33 (2): 691-696.PubMed
14.
go back to reference Anichini C, Lotti F, Longini M, Proietti F, Felici C, Perrone S, Buonocore G: Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi syndrome. Dis Markers. 2012, 33 (4): 179-183. 10.1155/2012/425205.CrossRefPubMedCentralPubMed Anichini C, Lotti F, Longini M, Proietti F, Felici C, Perrone S, Buonocore G: Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi syndrome. Dis Markers. 2012, 33 (4): 179-183. 10.1155/2012/425205.CrossRefPubMedCentralPubMed
15.
go back to reference Warburg O: Ueber den stoffwechsel der tumoren. 1930, Constable, London UK Warburg O: Ueber den stoffwechsel der tumoren. 1930, Constable, London UK
17.
go back to reference Heiden MGV, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324 (5930): 1029-1033. 10.1126/science.1160809.CrossRef Heiden MGV, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324 (5930): 1029-1033. 10.1126/science.1160809.CrossRef
18.
go back to reference Ferreira LMR: Cancer metabolism: the Warburg effect today. Exp Mol Pathol. 2010, 89 (3): 372-380. 10.1016/j.yexmp.2010.08.006.CrossRefPubMed Ferreira LMR: Cancer metabolism: the Warburg effect today. Exp Mol Pathol. 2010, 89 (3): 372-380. 10.1016/j.yexmp.2010.08.006.CrossRefPubMed
19.
go back to reference Hsu PP, Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell. 2008, 134 (5): 703-707. 10.1016/j.cell.2008.08.021.CrossRefPubMed Hsu PP, Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell. 2008, 134 (5): 703-707. 10.1016/j.cell.2008.08.021.CrossRefPubMed
20.
go back to reference Moisés Blanco Calvo AF, Enrique Grande P, Rosario García C, Luís Antón A: Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010, 2010: 14- Moisés Blanco Calvo AF, Enrique Grande P, Rosario García C, Luís Antón A: Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010, 2010: 14-
21.
go back to reference Ouwerkerk R, Jacobs MA, Macura KJ, Wolff AC, Stearns V, Mezban SD, Khouri NF, Bluemke DA, Bottomley PA: Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive Na-23 MRI. Breast Cancer Res Treat. 2007, 106 (2): 151-160. 10.1007/s10549-006-9485-4.CrossRefPubMed Ouwerkerk R, Jacobs MA, Macura KJ, Wolff AC, Stearns V, Mezban SD, Khouri NF, Bluemke DA, Bottomley PA: Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive Na-23 MRI. Breast Cancer Res Treat. 2007, 106 (2): 151-160. 10.1007/s10549-006-9485-4.CrossRefPubMed
22.
go back to reference Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, Cereijido M, Russo J: Sodium/potasium ATPase (Na+, K+ − ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs?. Breast Cancer Res Treat. 2006, 96 (1): 1-15. 10.1007/s10549-005-9053-3.CrossRefPubMed Chen JQ, Contreras RG, Wang R, Fernandez SV, Shoshani L, Russo IH, Cereijido M, Russo J: Sodium/potasium ATPase (Na+, K+ − ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs?. Breast Cancer Res Treat. 2006, 96 (1): 1-15. 10.1007/s10549-005-9053-3.CrossRefPubMed
23.
go back to reference Wang ZG: Roles of K+ channels in regulating tumor cell proliferation and apoptosis. Pflugers Arch. 2004, 448 (3): 274-286. 10.1007/s00424-004-1258-5.CrossRefPubMed Wang ZG: Roles of K+ channels in regulating tumor cell proliferation and apoptosis. Pflugers Arch. 2004, 448 (3): 274-286. 10.1007/s00424-004-1258-5.CrossRefPubMed
24.
go back to reference Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W: Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004, 15 (64(12)): 4294-4301. 10.1158/0008-5472.CAN-03-3884.CrossRef Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W: Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004, 15 (64(12)): 4294-4301. 10.1158/0008-5472.CAN-03-3884.CrossRef
26.
go back to reference Vinader V, Al-Saraireh Y, Wiggins HL, Rappoport JZ, Shnyder SD, Patterson LH, Afarinkia K: An agarose spot chemotaxis assay for chemokine receptor antagonists. J Pharmacol Toxicol Methods. 2011, 64 (3): 213-216. 10.1016/j.vascn.2011.01.004.CrossRefPubMed Vinader V, Al-Saraireh Y, Wiggins HL, Rappoport JZ, Shnyder SD, Patterson LH, Afarinkia K: An agarose spot chemotaxis assay for chemokine receptor antagonists. J Pharmacol Toxicol Methods. 2011, 64 (3): 213-216. 10.1016/j.vascn.2011.01.004.CrossRefPubMed
27.
go back to reference Wiggins HL, Rappoport JZ: An agarose spot assay for chemotactic invasion. Biotechniques. 2010, 48 (2): 120-123. 10.2144/000113353.CrossRef Wiggins HL, Rappoport JZ: An agarose spot assay for chemotactic invasion. Biotechniques. 2010, 48 (2): 120-123. 10.2144/000113353.CrossRef
28.
go back to reference Shackney SE: Tumor Growth, Cell Cycle Kinetics, and Cancer Treatment. 1993, McGraw Hill, New York Shackney SE: Tumor Growth, Cell Cycle Kinetics, and Cancer Treatment. 1993, McGraw Hill, New York
29.
go back to reference Brú A, Pastor JM, Fernaud I, Brú I, Melle S, Berenguer C: Super-rough dynamics on tumor growth. Phys Rev Lett. 1998, 81 (18): 4008-4011. 10.1103/PhysRevLett.81.4008.CrossRef Brú A, Pastor JM, Fernaud I, Brú I, Melle S, Berenguer C: Super-rough dynamics on tumor growth. Phys Rev Lett. 1998, 81 (18): 4008-4011. 10.1103/PhysRevLett.81.4008.CrossRef
30.
go back to reference Brú A, Albertos S, Subiza JL, García-Asenjo JL, Brú I: The universal dynamics of tumor growth. Biophys J. 2003, 85 (5): 2948-2961. 10.1016/S0006-3495(03)74715-8.CrossRefPubMedCentralPubMed Brú A, Albertos S, Subiza JL, García-Asenjo JL, Brú I: The universal dynamics of tumor growth. Biophys J. 2003, 85 (5): 2948-2961. 10.1016/S0006-3495(03)74715-8.CrossRefPubMedCentralPubMed
Metadata
Title
K-D:rib dampens Hs 578T cancer cell chemoinvasion and proliferation
Authors
Luca Bruni
Adesola A Babarinde
Ida Ortalli
Simonetta Croci
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2014
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-014-0077-9

Other articles of this Issue 1/2014

Cancer Cell International 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine